Epigenetic Therapy A novel two - drug treatment targets epigenetic alterations that help give
cancer cells their edge.
Not exact matches
New treatments for everything from
cancer to rare genetic diseases are entering the market all the time, many of which are cutting -
edge biologic medicines derived from living
cells.
Worse, after a biopsy, specialists spotted an even more disconcerting complication lurking at the
edge of the pathology specimen: stray
cancer cells.
Dr. McCabe said nanoparticles are a leading -
edge technology also being studied for delivery of drugs for other conditions, such as
cancer, heart disease, and bacterial infections, in order to target specific
cells to reduce toxicity and side effects of those medications and to make them more effective.
By carefully tracing a line of at least 2 millimeters outside of and around the
edges of a mole that is suspected of being a
cancer, doctors can remove all of its
cells and avert the need for a second surgery.
«Our study provides a cutting
edge advance in the field of
cancer immunotherapy and could specifically pave the way for more effective NK
cell - based immunotherapies.
They found that
cancer stem
cells seemed to appear in the highest numbers along the
edges of the engineered tumor environments, particularly where there were corners and convex curves.
In a paper published Feb. 19 in Nature
Cell Biology, the scientists show that a cutting -
edge technique called asymmetric flow field - flow fractionation (AF4) can efficiently sort nano - sized particles, called exosomes, that are secreted by
cancer cells and contain DNA, RNA, fats and proteins.
The demands of rapid
cell division put a strain on
cancer cells, and the approach works by tipping
cell stress over the
edge.
«It is quite an honor,» adds Wang, who was selected for the highly competitive award because he is applying new cutting -
edge tools to
cell metastasis, one of the most important areas of breast
cancer research.
Using cutting -
edge techniques enabled by next - generation sequencing, the authors generated complete methylome maps at single nucleotide resolution in a low - passage breast
cancer cell line and normal breast tissue (primary human mammary epithelial
cells).
Immune Design is a clinical - stage biotechnology company made up of collaborative, «can do», experienced professionals passionate about leveraging the company's leading -
edge technologies that target dendritic
cells for a more precise immune response for the treatment of
cancer and other chronic conditions.
But turning down the «thermostat» in a sense, may give the
cancer cell a survival
edge.
The overall goal of the
Cell Imaging Shared Resource is to supply VICC researchers with access to cutting
edge technology and expert technical support for microscopic observation and analysis of tissue and cellular anatomy and physiology related to
cancer research.
Their goal is to markedly reduce the chance that
cancer cells are present at the
edge of the lumpectomy specimen, thereby avoiding the expense and discomfort of repeat surgery to ensure that the tumor has been completely removed.
What we are seeing now are proposals based on cutting
edge science — areas related to
cancer and stem
cell research.
What we are seeing now are proposals based on cutting
edge science - areas related to
cancer and stem
cell research.
The object of surgery is to remove the entire tumor and leave clean
edges that have no
cancer cells.